A citation-based method for searching scientific literature

S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
Times Cited: 95







List of co-cited articles
561 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
264
28

Patients' and physicians' perspectives on pharmacogenetic testing.
Anja Rogausch, Daniela Prause, Anne Schallenberg, Jürgen Brockmöller, Wolfgang Himmel. Pharmacogenomics 2006
80
27


Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
32
59

Public perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
38
42

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Susanne B Haga, Julianne M O'Daniel, Genevieve M Tindall, Isaac R Lipkus, Robert Agans. Genet Med 2011
40
37

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
113
15

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
155
14

Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Emily A Fargher, Charlotte Eddy, William Newman, Faieza Qasim, Karen Tricker, Rachel A Elliott, Katherine Payne. Pharmacogenomics 2007
73
17

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
574
13

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
251
13

Development and implementation of a pharmacist-managed clinical pharmacogenetics service.
Kristine R Crews, Shane J Cross, John N McCormick, Donald K Baker, Alejandro R Molinelli, Richard Mullins, Mary V Relling, James M Hoffman. Am J Health Syst Pharm 2011
100
12

Factors influencing uptake of pharmacogenetic testing in a diverse patient population.
J O'Daniel, J Lucas, P Deverka, D Ermentrout, G Silvey, D F Lobach, S B Haga. Public Health Genomics 2010
22
54

Assessing patient readiness for the clinical adoption of personalized medicine.
A M Issa, W Tufail, J Hutchinson, J Tenorio, M Poonam Baliga. Public Health Genomics 2009
39
30

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
392
12

Stakeholder views on pharmacogenomic testing.
Haridarshan N Patel, Iulia D Ursan, Patrick M Zueger, Larisa H Cavallari, A Simon Pickard. Pharmacotherapy 2014
34
32

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Felix W Frueh, Shashi Amur, Padmaja Mummaneni, Robert S Epstein, Ronald E Aubert, Teresa M DeLuca, Robert R Verbrugge, Gilbert J Burckart, Lawrence J Lesko. Pharmacotherapy 2008
180
10

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
P H O'Donnell, A Bush, J Spitz, K Danahey, D Saner, S Das, N J Cox, M J Ratain. Clin Pharmacol Ther 2012
116
9

Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States.
John E Murphy, James S Green, Laura A Adams, Robert B Squire, Grace M Kuo, Alan McKay. Am J Pharm Educ 2010
85
10

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
263
9

Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.
Susanne B Haga, Kensaku Kawamoto, Robert Agans, Geoffrey S Ginsburg. Genet Med 2011
14
64

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
J A Johnson, L Gong, M Whirl-Carrillo, B F Gage, S A Scott, C M Stein, J L Anderson, S E Kimmel, M T M Lee, M Pirmohamed,[...]. Clin Pharmacol Ther 2011
419
8

Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
135
8

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
884
8

Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
41
19

Commercial pharmacogenetic-based decision-support tools in psychiatry.
Chad A Bousman, Malcolm Hopwood. Lancet Psychiatry 2016
62
12

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
R P McKillip, B A Borden, P Galecki, S A Ham, L Patrick-Miller, J P Hall, S Hussain, K Danahey, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
15
53

Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
Yee Ming Lee, Ryan P McKillip, Brittany A Borden, Catherine E Klammer, Mark J Ratain, Peter H O'Donnell. Pharmacogenet Genomics 2017
19
42

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
201
8

Pharmacogenetic testing: not as simple as it seems.
Susanne B Haga, Wylie Burke. Genet Med 2008
42
16

Estimation of the warfarin dose with clinical and pharmacogenetic data.
T E Klein, R B Altman, N Eriksson, B F Gage, S E Kimmel, M-T M Lee, N A Limdi, D Page, D M Roden, M J Wagner,[...]. N Engl J Med 2009
7

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
331
7


A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
496
7

An evaluation of pharmacists' expectations towards pharmacogenomics.
Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, Barbara Vadnais. Pharmacogenomics 2013
53
13

Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
Peter H O'Donnell, Keith Danahey, Michael Jacobs, Nisha R Wadhwa, Shennin Yuen, Angela Bush, Yasmin Sacro, Matthew J Sorrentino, Mark Siegler, William Harper,[...]. Am J Med Genet C Semin Med Genet 2014
79
8

Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists.
Katelyn M Alexander, Holly S Divine, Cathy R Hanna, Yevgeniya Gokun, Patricia R Freeman. J Am Pharm Assoc (2003) 2014
30
23

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, Richard M Weinshilboum, Liewei Wang, Kelly J Lyke, Euijung Ryu, Paul V Targonski, Michael D Van Norstrand, Matthew A Hathcock,[...]. Mayo Clin Proc 2014
181
7

Patient experiences with pharmacogenetic testing in a primary care setting.
Susanne B Haga, Rachel Mills, Jivan Moaddeb, Nancy Allen Lapointe, Alex Cho, Geoffrey S Ginsburg. Pharmacogenomics 2016
21
33

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
203
7

Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Amy A Lemke, Peter J Hulick, Dyson T Wake, Chi Wang, Annette W Sereika, Kristen Dilzell Yu, Nicole S Glaser, Henry M Dunnenberger. Pharmacogenomics 2018
17
41

Informed lay preferences for delivery of racially varied pharmacogenomics.
Jennifer L Bevan, Jonh A Lynch, Tasha N Dubriwny, Tina M Harris, Paul J Achter, Amy L Reeder, Celeste M Condit. Genet Med 2003
45
13

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
M V Relling, E E Gardner, W J Sandborn, K Schmiegelow, C-H Pui, S W Yee, C M Stein, M Carrillo, W E Evans, T E Klein. Clin Pharmacol Ther 2011
354
6

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.
S A Scott, K Sangkuhl, E E Gardner, C M Stein, J-S Hulot, J A Johnson, D M Roden, T E Klein, A R Shuldiner. Clin Pharmacol Ther 2011
306
6

Genomics and drug response.
Liewei Wang, Howard L McLeod, Richard M Weinshilboum. N Engl J Med 2011
372
6

The diffusion of innovation: factors influencing the uptake of pharmacogenetics.
Louise Fuks Nielsen, Claus Moldrup. Community Genet 2007
16
37

Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
Mary W Roederer, Marcia Van Riper, John Valgus, George Knafl, Howard McLeod. Per Med 2012
48
12

Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
Saskia C Sanderson, Jane Wardle, Martin J Jarvis, Steve E Humphries. Prev Med 2004
60
10

Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, R Mills, I M Lipkus, R Agans. Clin Genet 2012
29
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.